<DOC>
	<DOCNO>NCT01977131</DOCNO>
	<brief_summary>The aim study analyze safety , pulmonary function , image change patient silicosis treat autologous bone marrow stromal cell modification hepatocyte growth factor .</brief_summary>
	<brief_title>Safety Study Autologous Bone Marrow Stromal Cells With Modification Hepatocyte Growth Factor Treat Silicosis</brief_title>
	<detailed_description />
	<mesh_term>Silicosis</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>age 1850 , chronic accelerate silicosis , characterize fibrotic increase last two year , FEV1 &lt; 60 % &gt; 40 % , FVC &gt; 60 % SaO2 &gt; 90 % smoking , active tuberculosis infection , cancer , autoimmune disorder , hematological , hepatic cardiac disease , pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>